|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
' P8 d3 F6 j9 Twas to close its brain research facility in Basel, Switzerland,9 X* X% U3 s! X C4 ^5 H
the story noted that this move closely followed similar cuts
, i. O1 p( u/ l, k( z2 Iby rival pharmaceutical firms. As a report from the European College) b8 X: P* z9 {" V' Z- r
of Neuropsychopharmacology! ^- q+ t$ I1 o4 w' V
had warned a few months earlier, the
' d; b& C8 C F7 D8 V d. Xabandonment of research into new psychiatric drugs by AstraZeneca,6 m5 E. l+ w" C7 h7 S" z
GlaxoSmithKline
7 P6 _1 a& M0 nand others meant that “withdrawal of research- a3 F* z+ X3 V
resources is a withdrawal of hope for patients and their families”.
5 U7 v. [. O8 c. R$ Z; ^. e2 A4 F+ l& S9 J
/ `2 K% f1 F# X回复有免费下载链接
6 V, G5 p% P8 m% t' h% t, J1 g2 Q1 I! U ?- b1 u
|
-
总评分: 包包 + 20
查看全部评分
|